CXCR4-deficient prostate tumors were significantly smaller and less invasive as compared to control tumors, confirming the role of the CXCL12-CXCR4 axis in initiating tumor formation (Ao et al., 2007). The gene discussed is CXCR4; the disease is prostate neoplasm.